Celularity Inc (CELU)
3.08
0.00 (0.00%)
USD |
NASDAQ |
May 07, 14:26
Celularity Debt to Equity Ratio: 1.157 for Sept. 30, 2023
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2023 | 1.157 |
| June 30, 2023 | 0.2856 |
| March 31, 2023 | 0.2293 |
| December 31, 2022 | 0.1891 |
| September 30, 2022 | 0.239 |
| June 30, 2022 | 0.00 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.0137 |
| March 31, 2021 | |
| December 31, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2020
1.157
Maximum
Sep 2023
0.1922
Average
0.0137
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| NovaBay Pharmaceuticals Inc | 0.3431 |
| Palatin Technologies Inc | 0.00 |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 157.19M |
| Total Liabilities (Quarterly) | 126.94M |
| Shareholders Equity (Quarterly) | 30.25M |
| Current Ratio | 0.1949 |
| Net Debt Paydown Yield | -16.28% |